Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Sections
Personal tools
Log in
You are here: Home Protocols BRSCW Applicant: Diamandis - Mt Sinai (2006)

BRSCW Applicant: Diamandis - Mt Sinai (2006)

283
KLKs 5,6,7,8,10,11
Case/control
Proteomics
Breast and Gynecologic Cancers Research

Examine kallikreins as ovarian cancer biomarkers and determine sensitivity and specificity of panel


Examine kallikreins as ovarian cancer biomarkers and determine sensitivity and specificity of panel
Determine sensitivity and specificity of a panel of kallikreins for early ovarian cancer diagnosis
ELISA assays
An oral presentation by Dan Cramer was given at the 2009 AACR annual meeting

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.